A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination With Bendamustine and Rituximab Compared With Bendamustine and Rituximab Alone in Chinese Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL).
Cancer Non Hodgkin Lymphoma (NHL) Diffuse Large B-Cell Lymphoma (DLBCL)
For the latest version of this information please go to www.forpatients.roche.com